Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists

被引：9

作者：

Evindar, Ghotas ^{[1
]}

Bernier, Sylvie G. ^{[2
]}

Doyle, Elisabeth ^{[2
]}

Kavarana, Malcolm J. ^{[1
]}

Satz, Alexander L. ^{[1
]}

Lorusso, Jeanine ^{[2
]}

Blanchette, Heather S. ^{[2
]}

Saha, Ashis K. ^{[1
]}

Hannig, Gerhard ^{[2
]}

Morgan, Barry A. ^{[1
]}

Westlin, William F. ^{[2
]}

机构：

[1] Praecis Pharmaceut Inc, Dept Med Chem, Waltham, MA 02451 USA

[2] Praecis Pharmaceut Inc, Dept Preclin Res, Waltham, MA 02451 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 08期

关键词：

Sphingosine-1-phosphate (S1P) agonist; S1P(1) agonists; Phenylamide; Phenylimidazole; Immunosuppressants; Lymphopenia; ANALOGS; FTY720;

D O I：

10.1016/j.bmcl.2010.02.098

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In pursuit of a potent and highly selective sphingosine-1-phosphate receptor agonists with an improved in vivo conversion of the precursor to the active phospho-drug, we have utilized previously reported phenylamide and phenylimidazole scaffolds to identify a selectivity enhancing moiety (SEM) and selectivity enhancing orientation (SEO) within both pharmacophores. SEM and SEO have allowed for over 100 to 500-fold improvement in selectivity for S1P receptor subtype 1 over subtype 3. Utility of SEM and SEO and further SAR study allowed for discovery of a potent and selective preclinical candidate PPI-4955 (21b) with an excellent in vivo potency and dose responsiveness and markedly improved overall in vivo pharmacodynamic properties upon oral administration. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：2520 / 2524

页数：5

共 38 条

[21] Synthesis and structure-activity relationships of 1-benzylindane derivatives as selective agonists for estrogen receptor beta
Yonekubo, Shigeru
Fushimi, Nobuhiko
Miyagi, Takashi
Nakanishi, Osamu
Katsuno, Kenji
Ozawa, Motoyasu
Handa, Chiaki
Furuya, Noritaka
Muranaka, Hideyuki
BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (22) : 5895 - 5910
[22] 2' Biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling
Budzik, Brian
Garzya, Vincenzo
Shi, Dongchuan
Walker, Graham
Lauchart, Yann
Lucas, Adam J.
Rivero, Ralph A.
Langmead, Christopher J.
Watson, Jeannette
Wu, Zining
Forbes, Ian T.
Jin, Jian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3545 - 3549
[23] Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors
Dong, Jinyun
Huang, Guang
Cui, Qing
Meng, Qingqing
Li, Shaoshun
Cui, Jiahua
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
[24] Structural optimization of pyrazolo[1,5-a]pyrimidine derivatives as potent and highly selective DPP-4 inhibitors
Shen, Jian
Deng, Xinxian
Sun, Ran
Tavallaie, Mojdeh S.
Wang, Juntao
Cai, Qingqing
Lam, Celine
Lei, Shuwen
Fu, Lei
Jiang, Faqin
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
[25] Alignment independent 3D-QSAR studies and molecular dynamics simulations for the identification of potent and selective S1P1 receptor agonists
Alizadeh, Ali Akbar
Jafari, Behzad
Dastmalchi, Siavoush
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 94
[26] 2′ Biaryl amides as novel and subtype selective M1 agonists. Part I: Identification, synthesis, and initial SAR
Budzik, Brian
Garzya, Vincenzo
Shi, Dongchuan
Foley, James J.
Rivero, Ralph A.
Langmead, Christopher J.
Watson, Jeannette
Wu, Zining
Forbes, Ian T.
Jin, Jian
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3540 - 3544
[27] 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists
Scheiff, Anja B.
Yerande, Swapnil G.
El-Tayeb, Ali
Li, Wenjin
Inamdar, Gajanan S.
Vasu, Kamala K.
Sudarsanam, Vasudevan
Mueller, Christa E.
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (06) : 2195 - 2203
[28] Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists
Budzik, Brian
Garzya, Vincenzo
Shi, Dongchuan
Walker, Graham
Woolley-Roberts, Marie
Pardoe, Joanne
Lucas, Adam
Tehan, Ben
Rivero, Ralph A.
Langmead, Christopher J.
Watson, Jeannette
Wu, Zining
Forbes, Ian T.
Jin, Jian
ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (06): : 244 - 248
[29] Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies
Francesconi, Valeria
Cichero, Elena
Kanov, Evgeny V.
Laurini, Erik
Pricl, Sabrina
Gainetdinov, Raul R.
Tonelli, Michele
PHARMACEUTICALS, 2020, 13 (11) : 1 - 26
[30] Design of Novel Neurokinin 1 Receptor Antagonists Based on Conformationally Constrained Aromatic Amino Acids and Discovery of a Potent Chimeric Opioid Agonist-Neurokinin 1 Receptor Antagonist
Ballet, Steven
Feytens, Debby
Buysse, Koen
Chung, Nga N.
Lemieux, Carole
Tumati, Suneeta
Keresztes, Attila
Van Duppen, Joost
Lai, Josephine
Varga, Eva
Porreca, Frank
Schiller, Peter W.
Broeck, Jozef Vanden
Tourwe, Dirk
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (07) : 2467 - 2476

← 1 2 3 4 →